Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06072781Phase 3Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
PrincipalinvestigatorStart date: 2024-03-18
NCT04625270Phase 2Active Not Recruiting
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
Low Grade Ovarian Serous AdenocarcinomaOvarian Cancer
PrincipalinvestigatorStart date: 2020-12-21

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Susana Banerjee, MBBS,MA,PhD

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Moderately Similar
1 trials

Shared therapeutic areas:

Low Grade Ovarian Serous AdenocarcinomaOvary CancerRecurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Worked with same sponsors:

European Network of Gynaecological Oncological Trial Groups (ENGOT)GOG Foundation+1 more
Collaborated on 1 trial
Similarity Score34%

MD Verastem

Verastem, Inc.

Moderately Similar
5 trials

Shared therapeutic areas:

Low Grade Ovarian Serous AdenocarcinomaOvary CancerRecurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Worked with same sponsors:

European Network of Gynaecological Oncological Trial Groups (ENGOT)GOG Foundation+1 more
Collaborated on 1 trial
Similarity Score34%

Susana Banerjee, MBBS, MA, PhD

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Related
1 trials

Shared therapeutic areas:

Low Grade Serous Ovarian CancerRecurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Worked with same sponsors:

Australia New Zealand Gynaecological Oncology GroupEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)+3 more
Collaborated on 1 trial
Similarity Score24%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score8%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score8%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score8%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Ovary Cancer

Worked with same sponsors:

Verastem, Inc.
Similarity Score8%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score8%

Sandro Pignata, M.D., Ph.D.

National Cancer Institute, Naples

Related
9 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score8%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06072781Phase 3PrincipalInvestigator

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

Low Grade Serous Ovarian Cancer
Recruiting
NCT04625270Phase 2PrincipalInvestigator

A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation

Low Grade Ovarian Serous AdenocarcinomaOvarian Cancer
Active Not Recruiting

All 2 trials loaded